American Well - AMWL Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $12.50
  • Forecasted Upside: 58.83%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$7.87
▲ +0.03 (0.38%)

This chart shows the closing price for AMWL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New American Well Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMWL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMWL

Analyst Price Target is $12.50
▲ +58.83% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for American Well in the last 3 months. The average price target is $12.50, with a high forecast of $15.00 and a low forecast of $10.50. The average price target represents a 58.83% upside from the last price of $7.87.

This chart shows the closing price for AMWL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 4 polled investment analysts is to hold stock in American Well. This rating has held steady since January 2023, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/22/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/17/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$20.00 ➝ $10.50
10/31/2024Needham & Company LLCReiterated RatingHold
9/24/2024Needham & Company LLCReiterated RatingHold
8/6/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$40.00 ➝ $15.00
8/1/2024Needham & Company LLCReiterated RatingHold
5/23/2024UBS GroupLower TargetNeutral ➝ Neutral$30.00 ➝ $12.00
5/2/2024Needham & Company LLCReiterated RatingHold
4/15/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$35.00 ➝ $20.00
11/2/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$50.00 ➝ $35.00
8/3/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$100.00 ➝ $50.00
3/23/2023TD CowenDowngradeOutperform ➝ Market Perform$100.00 ➝ $50.00
3/15/2023GuggenheimReiterated RatingBuy$100.00
3/13/2023Morgan StanleyLower TargetOverweight$120.00 ➝ $100.00
2/27/2023CowenLower Target$180.00 ➝ $100.00
2/27/2023Piper SandlerDowngradeOverweight ➝ Neutral$100.00 ➝ $70.00
2/23/2023Needham & Company LLCReiterated RatingHold
2/23/2023GuggenheimLower Target$120.00 ➝ $100.00
2/23/2023Credit Suisse GroupLower TargetNeutral$100.00 ➝ $80.00
1/6/2023Morgan StanleyLower TargetOverweight$140.00 ➝ $120.00
1/4/2023Bank of AmericaUpgradeNeutral ➝ Buy$84.00
9/7/2022Truist FinancialInitiated CoverageHold$100.00
9/7/2022Piper SandlerLower Target$120.00 ➝ $100.00
6/23/2022Piper SandlerBoost TargetOverweight$100.00 ➝ $120.00
5/16/2022Piper SandlerReiterated RatingOverweight$140.00 ➝ $100.00
4/13/2022GuggenheimInitiated CoverageBuy$120.00
2/28/2022Wells Fargo & CompanyLower TargetEqual Weight$120.00 ➝ $80.00
2/25/2022Piper SandlerLower Target$240.00 ➝ $140.00
2/11/2022The Goldman Sachs GroupInitiated CoverageNeutral$120.00
12/17/2021Morgan StanleyLower TargetOverweight$240.00 ➝ $180.00
12/1/2021Jefferies Financial GroupInitiated CoverageHold$120.00
11/12/2021CowenLower TargetOutperform$500.00 ➝ $360.00
11/12/2021Morgan StanleyLower TargetOverweight$320.00 ➝ $240.00
11/11/2021Credit Suisse GroupLower TargetNeutral$270.00 ➝ $220.00
11/11/2021Piper SandlerLower TargetOverweight$320.00 ➝ $240.00
10/18/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$160.00
9/14/2021Cantor FitzgeraldInitiated CoverageOverweight$300.00
8/31/2021Morgan StanleyLower TargetOverweight$360.00 ➝ $320.00
8/24/2021CowenLower TargetOutperform$580.00 ➝ $500.00
8/12/2021Credit Suisse GroupLower TargetNeutral$350.00 ➝ $270.00
7/2/2021Morgan StanleyLower TargetOverweight$640.00 ➝ $360.00
5/17/2021GuggenheimUpgradeNeutral ➝ Buy$300.00
5/13/2021Credit Suisse GroupLower TargetNeutral$460.00 ➝ $350.00
5/13/2021Piper SandlerLower TargetOverweight$600.00 ➝ $400.00
4/16/2021KeyCorpInitiated CoverageSector Weight ➝ Sector Weight
4/15/2021Needham & Company LLCInitiated CoverageHold
3/26/2021Morgan StanleyLower TargetOverweight$660.00 ➝ $640.00
3/25/2021CowenLower TargetOutperform$820.00 ➝ $700.00
3/25/2021Piper SandlerLower TargetOverweight$900.00 ➝ $600.00
2/22/2021Piper SandlerBoost TargetOverweight$880.00 ➝ $900.00
1/27/2021Credit Suisse GroupDowngradeOutperform ➝ Neutral$820.00
1/6/2021BTIG ResearchInitiated CoverageNeutral
12/18/2020Stifel NicolausInitiated CoverageHold$580.00
12/17/2020Stifel NicolausInitiated CoverageHold$580.00
11/18/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$520.00
10/23/2020GuggenheimInitiated CoverageNeutral
10/12/2020CowenInitiated CoverageOutperform$820.00
10/12/2020Morgan StanleyInitiated CoverageEqual Weight$700.00
10/12/2020UBS GroupInitiated CoverageNeutral$580.00
10/12/2020Credit Suisse GroupInitiated CoverageOutperform$820.00
10/12/2020Berenberg BankInitiated CoverageBuy$780.00
10/12/2020The Goldman Sachs GroupInitiated CoverageNeutral$620.00
10/12/2020Piper SandlerInitiated CoverageOverweight$880.00
(Data available from 12/22/2019 forward)

News Sentiment Rating

1.02 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 5 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/26/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/25/2024
  • 6 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
7/25/2024
  • 5 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/24/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/23/2024
  • 6 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/23/2024
  • 2 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/22/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/22/2024

Current Sentiment

  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

American Well logo
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $7.87
Low: $7.60
High: $7.99

50 Day Range

MA: $9.14
Low: $7.81
High: $10.38

52 Week Range

Now: $7.87
Low: $5.00
High: $31.60

Volume

92,758 shs

Average Volume

103,744 shs

Market Capitalization

$120.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.07

Frequently Asked Questions

What sell-side analysts currently cover shares of American Well?

The following sell-side analysts have issued stock ratings on American Well in the last year: Morgan Stanley, Needham & Company LLC, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for AMWL.

What is the current price target for American Well?

0 Wall Street analysts have set twelve-month price targets for American Well in the last year. Their average twelve-month price target is $12.50, suggesting a possible upside of 58.8%. Wells Fargo & Company has the highest price target set, predicting AMWL will reach $15.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $10.50 for American Well in the next year.
View the latest price targets for AMWL.

What is the current consensus analyst rating for American Well?

American Well currently has 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AMWL, but not buy more shares or sell existing shares.
View the latest ratings for AMWL.

What other companies compete with American Well?

How do I contact American Well's investor relations team?

American Well's physical mailing address is 75 STATE STREET 26TH FLOOR, Boston MA, 02109. The company's listed phone number is 617-204-3500 and its investor relations email address is [email protected]. The official website for American Well is amwell.com. Learn More about contacing American Well investor relations.